Literature DB >> 23255792

CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.

Lichen Jing1, Joshua T Schiffer, Tiana M Chong, Joseph J Bruckner, D Huw Davies, Phillip L Felgner, Juergen Haas, Anna Wald, G M G M Verjans, David M Koelle.   

Abstract

Little is known concerning immunodominance within the CD4 T-cell response to viral infections and its persistence into long-term memory. We tested CD4 T-cell reactivity against each viral protein in persons immunized with vaccinia virus (VV), either recently or more than 40 years ago, as a model self-limited viral infection. Similar tests were done with persons with herpes simplex virus 1 (HSV-1) infection as a model chronic infection. We used an indirect method capable of counting the CD4 T cells in blood reactive with each individual viral protein. Each person had a clear CD4 T-cell dominance hierarchy. The top four open reading frames accounted for about 40% of CD4 virus-specific T cells. Early and long-term memory CD4 T-cell responses to vaccinia virus were mathematically indistinguishable for antigen breadth and immunodominance. Despite the chronic intermittent presence of HSV-1 antigen, the CD4 T-cell dominance and diversity patterns for HSV-1 were identical to those observed for vaccinia virus. The immunodominant CD4 T-cell antigens included both long proteins abundantly present in virions and shorter, nonstructural proteins. Limited epitope level and direct ex vivo data were also consistent with pronounced CD4 T-cell immunodominance. We conclude that human memory CD4 T-cell responses show a pattern of pronounced immunodominance for both chronic and self-limited viral infections and that this pattern can persist over several decades in the absence of antigen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255792      PMCID: PMC3571405          DOI: 10.1128/JVI.03047-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Least effort and the origins of scaling in human language.

Authors:  Ramon Ferrer i Cancho; Ricard V Sole
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

2.  Duration of antiviral immunity after smallpox vaccination.

Authors:  Erika Hammarlund; Matthew W Lewis; Scott G Hansen; Lisa I Strelow; Jay A Nelson; Gary J Sexton; Jon M Hanifin; Mark K Slifka
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

Review 3.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

Review 4.  T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.

Authors:  Laura M Snell; Gloria H Y Lin; Ann J McPherson; Theo J Moraes; Tania H Watts
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

7.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

8.  Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.

Authors:  Nicholas J Moss; Amalia Magaret; Kerry J Laing; Angela Shaulov Kask; Minna Wang; Karen E Mark; Joshua T Schiffer; Anna Wald; David M Koelle
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

9.  Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.

Authors:  William W Kwok; Venus Tan; Laurie Gillette; Christopher T Littell; Michele A Soltis; Rebecca B LaFond; Junbao Yang; Eddie A James; Jonathan H DeLong
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

10.  Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss.

Authors:  S M Varga; L K Selin; R M Welsh
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

View more
  20 in total

1.  p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.

Authors:  Nicola R Hardwick; Paul Frankel; Christopher Ruel; Julie Kilpatrick; Weimin Tsai; Ferdynand Kos; Teodora Kaltcheva; Lucille Leong; Robert Morgan; Vincent Chung; Raechelle Tinsley; Melissa Eng; Sharon Wilczynski; Joshua D I Ellenhorn; Don J Diamond; Mihaela Cristea
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

2.  p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses.

Authors:  Nicola R Hardwick; Mary Carroll; Teodora Kaltcheva; Dajun Qian; Dean Lim; Lucille Leong; Peiguo Chu; Joseph Kim; Joseph Chao; Marwan Fakih; Yun Yen; Jonathan Espenschied; Joshua D I Ellenhorn; Don J Diamond; Vincent Chung
Journal:  Clin Cancer Res       Date:  2014-07-01       Impact factor: 12.531

Review 3.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

4.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

5.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

6.  Genome-Wide Approach to the CD4 T-Cell Response to Human Herpesvirus 6B.

Authors:  Derek J Hanson; Olga Tsvetkova; Guilhem F Rerolle; Alexander L Greninger; Allesandro Sette; Lichen Jing; Victoria L Campbell; David M Koelle
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

7.  Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.

Authors:  Victoria L Campbell; LeAnn Nguyen; Elise Snoey; Christopher L McClurkan; Kerry J Laing; Lichun Dong; Alessandro Sette; Cecilia S Lindestam Arlehamn; Danny M Altmann; Rosemary J Boyton; Justin A Roby; Michael Gale; Mars Stone; Michael P Busch; Phillip J Norris; David M Koelle
Journal:  Immunohorizons       Date:  2020-08-04

Review 8.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

Review 9.  Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

Authors:  Shane C McAllister; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2014-07-31       Impact factor: 5.217

10.  Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.

Authors:  Lichen Jing; Kerry J Laing; Lichun Dong; Ronnie M Russell; Russell S Barlow; Juergen G Haas; Meena S Ramchandani; Christine Johnston; Soren Buus; Alec J Redwood; Katie D White; Simon A Mallal; Elizabeth J Phillips; Christine M Posavad; Anna Wald; David M Koelle
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.